Company: ABBV
Filing Date: 2025-02-14
Form Type: 10-K
Source: 0001551152-25-000020
Chunk: 49

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 10-K
Item: Item 3
Chunk 49
---
ITEM 3. LEGAL PROCEEDINGS

Information pertaining to legal proceedings is provided in Note 15, "Legal Proceedings and Contingencies" to the Consolidated Financial Statements included under Item 8, "Financial Statements and Supplementary Data," and is incorporated by reference herein.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

27     |  2024 Form 10-K

INFORMATION ABOUT OUR EXECUTIVE OFFICERS

Name Age PositionRichard A. Gonzalez71Executive Chairman of the Board and Retired Chief Executive OfficerRobert A. Michael54Chief Executive OfficerScott T. Reents57Executive Vice President, Chief Financial OfficerNicholas J. Donoghoe, M.D.44Executive Vice President, Chief Business and Strategy OfficerTimothy J. Richmond58Executive Vice President, Chief Human Resources OfficerAzita Saleki-Gerhardt, Ph.D.61Executive Vice President, Chief Operations OfficerPerry C. Siatis50Executive Vice President, General Counsel and SecretaryJeffrey R. Stewart56Executive Vice President, Chief Commercial OfficerRoopal Thakkar, M.D.53Executive Vice President, Research & Development and Chief Scientific OfficerKevin K. Buckbee59Senior Vice President, Controller

_______________________________________________________________________________

Mr. Gonzalez is the Executive Chairman of the Board. Mr. Gonzalez served as Chairman and Chief Executive Officer of AbbVie from 2013 to June 2024. He served as Abbott’s Executive Vice President of the pharmaceutical products group from July 2010 to December 2012, and was responsible for Abbott’s worldwide pharmaceutical business, including commercial operations, research and development, and manufacturing. He also served as President, Abbott Ventures Inc., Abbott’s medical technology investment arm, from 2009 to 2011. Mr. Gonzalez joined Abbott in 1977 and held various management positions before briefly retiring in 2007, including: Abbott’s President and Chief Operating Officer; President, Chief Operating Officer of Abbott’s Medical Products Group; Senior Vice President and President of Abbott’s former Hospital Products Division; Vice President and President of Abbott’s Health Systems Division; and Divisional Vice President and General Manager for Abbott’s Diagnostics Operations in the United States and Canada. On February 13, 2025, the Board of Directors of AbbVie unanimously elected Mr. Michael to succeed Mr. Gonzalez as Chairman of the Board of Directors, effective July 1, 2025, at which time Mr. Gonzalez will retire from the Board.